The Lancet: Some lung cancer patients could live longer when treated with new radiotherapy strategy

Treating advanced small-cell lung cancer with thoracic (or chest) radiotherapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50%, according to new research published in The Lancet and being presented simultaneously at ASTRO’s 2014 Annual Meeting in San Francisco.